IRCT201010172000N4Completed未知
Gabapentin as a combination treatment with lithium in adolescents with bipolar disorder: a double- blind, randomized, placebo-controlled clinical trial
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Enrollment
- 31
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 10 years to 17 years (—)
- Sex
- All
Inclusion Criteria
- •1)10 -17 years of age 2) score more than 20 in Young Mania Rating Scale (YMRS, Yongstorm , et al, 2003) 3)not being on any psychiatric medication for at least two weeks prior to entry into this trial 4) signing a written informed consent. Exclusion criteria: 1) any significant medical illness, 2) IQ lower than70, 3) meeting criteria for substance dependence and abuse in the month before trial
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Effect of giving Gabapentin and trihexphenidyl when compared to Trihexphenidyl alone for reducing dystonia in children with cerebral palsyCTRI/2019/04/018603JAYA SHANKAR KAUSHIK
Completed
Not Applicable
The comparative study of combination Gabapentin and topiramate vs treatment alone topiramate or Gabapentin of painful diabetic neuropathyDiabetic neuropathy.Insulin-dependent diabetes mellitus with neurological complicationsIRCT201108287432N1Kermanshah University of Medical Sciences150
Recruiting
Not Applicable
Topical Gabapentin Amitriptyline and Lignocaine (ToGA) ointment trial for posthaemorrhoidectomy analgesiaACTRN12616001477415Monash Health166
Not yet recruiting
Not Applicable
Evaluation of Gabapentin as a drug that helps in postoperative pain management of Knee SurgerySprain and strain involving (anterior) (posterior) cruciate ligament of kneeM00-M99RBR-3zvc3sInstituto de Ortopedia e Traumatologia de Joinville
Recruiting
Phase 3
The effect of combination therapy of L-glutamine and hydroxyurea in patients with sickle cell anemiaSickle cell anemia, L-glutamine, hydroxyurea, pain crisis.Sickle-cell disorders, Sickle-cell anaemia with crisis, Sickle-cell anaemia without crisis, Double heterozygous sickling disorders, Sickle-cell trait, Other sickle-cell disordersIRCT20210715051904N1Boushehr University of Medical Sciences126